Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 5.18% insiders, and 94.81% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.59% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Abeona Therapeutics	-	5.18%	94.81%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	1	-	2,350	-	-	-	1	-	-	-
Sep 30, 2022	2	-94.44%	153,702	-99.26%	2	1.16%	-	-100.00%	2	-60.00%
Jun 30, 2022	36	-26.53%	20,889,690	-35.97%	14	2.84%	11	-31.25%	5	-66.67%
Mar 31, 2022	49	4.26%	32,623,572	-20.40%	22	1.30%	16	-27.27%	15	25.00%
Dec 31, 2021	47	-16.07%	40,985,649	61.98%	41	6.24%	22	22.22%	12	-36.84%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.33M	2.59%	-
Vanguard US Total Market Shares ETF	1.23M	2.53%	-
iShares Russell 2000 ETF	1.06M	2.08%	-17.20K
Vanguard Institutional Extnd Mkt Idx Tr	805.68K	1.57%	127.58K
Simplify Propel Opportunities ETF	558.58K	1.09%	-
Kennedy Micro Cap	529.32K	1.03%	37.89K
iShares Russell 2000 Growth ETF	358.01K	0.70%	-890.00
Fidelity Extended Market Index	267.50K	0.52%	42.26K
abrdn Life Sciences Investors	224.36K	0.46%	-
Vanguard Russell 2000 ETF	222.29K	0.43%	222.29K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 22, 2025	Vazzano Joseph Walter	Chief Financial Officer	Sell	$9.97K
Jul 09, 2025	Silverstein Christine Berni	-	Sell	$76.67K
Jul 09, 2025	Seshadri Vishwas	Chief Executive Officer	Sell	$406.50K
Jul 09, 2025	Vazzano Joseph Walter	Chief Financial Officer	Sell	$148.80K
Jul 08, 2025	Wuchterl Donald A.	-	Sell	$30.15K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	8
2025 Q2	-	5
2025 Q1	-	3
2024 Q4	-	-
2024 Q3	-	-

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 5.18% insiders and 94.82% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 64.05%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Abeona Therapeutics shares, with 2.59% of its total shares outstanding invested in 1.33M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools